The Role of Wearable Devices in Cardiothoracic Surgery: Predicting and Detecting Early Postoperative Complications

Launched by MASSACHUSETTS GENERAL HOSPITAL · Mar 26, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at how wearable devices, like fitness trackers and smartwatches, can help monitor patients who have just undergone heart or lung surgery. The goal is to use advanced technology to gather detailed information about patients' recovery and to spot any early complications that might arise after surgery. By doing this, the researchers hope to improve patient care and outcomes.

To take part in the study, participants need to be at least 18 years old and scheduled for cardiothoracic surgery. They should be able to use one of the wearable devices provided and be capable of understanding and agreeing to the study's requirements. However, individuals with certain health issues, such as severe lung problems or liver disease, and pregnant women are not eligible. Participants can expect to wear a device that tracks their health data, which will help doctors monitor their recovery more closely. This innovative approach aims to enhance the way post-surgery care is delivered and ensure that patients receive timely support if complications occur.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age 18 years or older undergoing cardiothoracic surgery that is male or a non-pregnant female and are amenable to using one of the wearable devices of interest (Fitbit, iWatch, Biostrap).
• • 2. Individuals willing to provide informed consent and who have capacity for all study procedures
• Exclusion Criteria:
• • 1. Individuals with mental incapacity and/or cognitive impairment that would preclude adequate understanding of, or cooperation with the study protocol.
• • 2. Any pregnant participant.
• • 3. Severe irreversible pulmonary hypertension.
• • 4. Congenital heart disease
• • 5. Chronic renal insufficiency or undergoing chronic renal replacement therapy
• • 6. Liver cirrhosis